Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer
Authors
Keywords
Tumor immunology, Immunotherapy, Tumor antigens, Somatic mutations, Oncogenomics, NIBIT 2013
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 64, Issue 1, Pages 99-104
Publisher
Springer Nature
Online
2014-08-27
DOI
10.1007/s00262-014-1599-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
- (2014) M. Rajasagi et al. BLOOD
- Shaping the repertoire of tumor-infiltrating effector and regulatory T cells
- (2014) Peter A. Savage et al. IMMUNOLOGICAL REVIEWS
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- HLA-Binding Properties of Tumor Neoepitopes in Humans
- (2014) E. F. Fritsch et al. Cancer Immunology Research
- Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges
- (2013) Pramod K. Srivastava et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lessons from the Cancer Genome
- (2013) Levi A. Garraway et al. CELL
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4
- (2013) A. Volonte et al. JOURNAL OF IMMUNOLOGY
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
- (2013) Paul F Robbins et al. NATURE MEDICINE
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Bioinformatics for cancer immunology and immunotherapy
- (2012) Pornpimol Charoentong et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Exploiting the Mutanome for Tumor Vaccination
- (2012) J. C. Castle et al. CANCER RESEARCH
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
- (2012) Hirokazu Matsushita et al. NATURE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- Epitope Landscape in Breast and Colorectal Cancer
- (2008) N. H. Segal et al. CANCER RESEARCH
- Immune epitope database analysis resource (IEDB-AR)
- (2008) Q. Zhang et al. NUCLEIC ACIDS RESEARCH
- NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11
- (2008) Claus Lundegaard et al. NUCLEIC ACIDS RESEARCH
- Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan
- (2008) Morten Nielsen et al. PLoS Computational Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started